Manufacturing Material Planning Specialist at Bristol-Myers Squibb

Boudry, Neuchatel, Switzerland

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Manufacturing, BiotechnologyIndustries

Requirements

At least 3 years’ experience in the field of supply chain planning, especially on purchasing and procurement
Experience in an industrial international environment, knowledge of the pharmaceutical environment and GMP-experience
Capability to work in a changing environment and beyond pre-defined processes and to actively contribute to defining new structures
Foster close working relationship, collaboration and teamwork with associated departments
Conscientious, reliable in action follow-up, eager to challenge status quo
Strong ability to handle multiple tasks and to adapt to change
Be proactive (with an eye for anticipation and continuous improvement) and team oriented
Good communication, problem-solving and decision-making skills
Extensive experience with SAP planning software, excellent IT proficiency: MS Office, Excel, SharePoint
Fluency both in French and English

Responsibilities

Assist in the weekly PO cycle by monitoring acknowledgments to ensure timely confirmation and processing
Manage annual PO activities related to transportation and ink procurement
Oversee the PO lifecycle from issuance through to Accounts Payable, including QA release coordination
Help maintain optimal inventory levels aligned with coverage strategies
Monitor and initiate destruction processes for materials impacted by labeling changes, minimum picking quantities (MPQ), retest requirements, and expiration dates
Consolidate quarterly forecasts for direct material suppliers
Assist in calculating and reporting monthly KPIs related to material planning
Maintain vendor master data for buy items linked to BOMs in SAP, including price and source list updates
Review and validate tickets for item creation, adjustment, or obsolescence
Track new item creation and resolve SAP discrepancies, ensuring issues are followed through to resolution
Ensure all relevant documentation (e.g., Work Instructions, SOPs) is properly maintained and archived in accordance with compliance standards

Skills

GMP

Supply Chain

Purchase Order Management

Inventory Management

Forecasting

Logistics

PO Lifecycle

KPI

Process Improvements

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free